文献速递焦虑、强迫与应激相关障碍物质与行为成瘾

症状激发与经颅磁刺激临床反应:系统综述与荟萃分析

Symptom Provocation and Clinical Response to Transcranial Magnetic Stimulation: A Systematic Review and Meta-Analysis.
PubMed 文献 · JAMA Psychiatry · 2025-01-01

该系统综述与荟萃分析纳入71项随机临床试验(3246名参与者),评估症状激发对经颅磁刺激(TMS)治疗强迫症(OCD)和尼古丁依赖临床反应的影响。结果显示,在OCD研究中,无论是否激发,活性TMS均优于伪刺激;在尼古丁依赖研究中,仅激发时活性TMS优于伪刺激。激发额外效应在两种疾病中均未达统计学显著性。

要点

  • OCD研究中,活性TMS在激发(SMD=-0.51)和非激发(SMD=-0.29)条件下均优于伪刺激。
  • 尼古丁依赖研究中,活性TMS仅在激发条件下优于伪刺激(SMD=-0.56),非激发条件未达显著。
  • 症状激发的额外效应在OCD(SMD=-0.22)和尼古丁依赖(SMD=-0.21)中均不显著。

核心结论

  • 症状激发可能增强TMS对OCD和尼古丁依赖的临床反应,但激发额外效应未达统计学显著性。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、CINAHL、Embase、PsycInfo至2024年8月30日,纳入71项随机临床试验(3246名参与者),其中63项研究(2998名参与者)进入荟萃分析。

临床怎么用

  • 对于OCD和尼古丁依赖的TMS治疗,临床可考虑在刺激时结合症状激发以可能增强疗效。

局限性

  • 比较激发与非激发TMS的研究有限,需专门设计对照试验以确立激发的因果效应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Transcranial magnetic stimulation (TMS), a form of noninvasive brain stimulation used to treat major depressive disorder, obsessive-compulsive disorder (OCD), and nicotine dependence, has well-established state-dependent effects on brain circuitry. However, a major question for TMS remains: does brain state affect clinical response? OBJECTIVE: To quantify the association between symptom provocation and clinical response to TMS for OCD and nicotine dependence, the only Food and Drug Administration-cleared TMS indications with symptom provocation. DATA SOURCES: PubMed, CINAHL, Embase, PsycInfo until August 30, 2024. STUDY SELECTION: Randomized clinical trials of TMS for OCD or nicotine dependence with a clinical outcome. Of 600 studies identified, 71 met inclusion criteria. DATA EXTRACTION AND SYNTHESIS: Data extraction was completed independently by 2 extractors and cross-checked by a third. Standardized mean difference (SMD) and SE were estimated via Hedges g and synthesized data in a 3-level random-effects meta-analysis. Study data were analyzed from August 2023 to March 2025. MAIN OUTCOMES AND MEASURES: Primary outcomes were clinical response measures. RESULTS: A total of 71 studies met inclusion criteria and included 3246 participants (mean [SD] age; 37.8 [8.0] years; mean [SD] percentage female, 44.1% [17.2%]). Included in the meta-analysis were 63 studies with 2998 participants. For OCD studies, active TMS was associated with better clinical response than sham both with (SMD = -0.51; 95% CI, -0.96 to -0.07; P = 0.04) and without (SMD = -0.29; 95% CI, -0.40 to -0.17; P < .001) symptom provocation. For nicotine use, active TMS was associated with better clinical response than sham when used with (SMD = -0.56; 95% CI, -1.12 to 0; P = .05) but not without (SMD = -0.35; 95% CI, -0.74 to 0.04; P = .08) symptom provocation. For OCD studies, the estimated expected added effect of provocation was SMD of -0.22 (95% CI, -0.65 to 0.20; P = .22). In nicotine studies, the estimated expected added effect of provocation was SMD of -0.21 (95% CI, -1.00 to 0.58; P = .57). CONCLUSIONS AND RELEVANCE: Results of this systematic review and meta-analysis suggest that symptom provocation may enhance clinical response to TMS for OCD and nicotine dependence. Studies comparing TMS with and without provocation are critical to establish the causal effect of provocation.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Bello D, Jones M, Gadiyar I, et al. Symptom Provocation and Clinical Response to Transcranial Magnetic Stimulation: A Systematic Review and Meta-Analysis. JAMA Psychiatry. 2025. PMID: 40465306. doi:10.1001/jamapsychiatry.2025.0792

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。